Integral Diagnostics Limited (ASX:IDX)
2.140
+0.020 (0.94%)
Oct 7, 2026, 4:10 PM AEST
Integral Diagnostics Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Integral Diagnostics stock has a consensus rating of "Buy" and an average price target of $2.99. The average 1-year stock price forecast is 39.72% higher than the current stock price, while the lowest is $2.24 (+4.67%) and the highest is $3.70 (+72.90%).
Price Target: $2.99 (+39.72%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Integral Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 3 | 3 | 4 | 4 | 4 | 3 |
| Hold | 0 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 13 | 13 | 14 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $3.20 | Buy | Maintains | $3.20 | +49.53% | Sep 15, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $3.70 | Buy | Maintains | $3.70 | +72.90% | Sep 8, 2026 |
| Jefferies | Jefferies | Buy Maintains $3.50 → $3.30 | Buy | Maintains | $3.50 → $3.30 | +54.21% | Aug 27, 2026 |
| Jarden | Jarden | Buy Maintains $2.95 | Buy | Maintains | $2.95 | +37.85% | Aug 27, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $3.60 → $3.15 | Buy | Maintains | $3.60 → $3.15 | +47.20% | Aug 26, 2026 |
Financial Forecast
Revenue This Year
837.19M
from 788.62M
Increased by 6.16%
Revenue Next Year
884.33M
from 837.19M
Increased by 5.63%
EPS This Year
0.13
from 0.13
Increased by 6.22%
EPS Next Year
0.16
from 0.13
Increased by 16.05%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.